Literature DB >> 20543609

Identifying and characterizing recently transmitted viruses.

Brandon F Keele1.   

Abstract

PURPOSE OF REVIEW: Improvements in sequencing approaches and robust mathematical modeling have dramatically increased information on viral genetics during acute infection with HIV and simian immunodeficiency virus, providing unprecedented insight into viral transmission and viral/immune interactions. RECENT
FINDINGS: Overall viral genetic diversity is reduced significantly during mucosal transmission. Remarkably, in the vast majority of sexual transmissions, this diversity is reduced to a single viral variant that establishes the initial productive clinical infection. By identifying and enumerating transmitted/founder viruses, researchers can begin to define the characteristics that are necessary and sufficient for successful viral replication within a new host.
SUMMARY: Acute HIV infection is a critical window of opportunity for vaccine and therapeutic intervention. New sequencing technologies and mathematical modeling of transmission and early evolution have provided a clearer understanding of the number of founder viruses that establish infection, the rapid generation of diversity in these viruses and the subsequent evasion of host immunity. The information gained by identifying transmitted viruses, monitoring the initial host responses to these viruses and then identifying mechanisms of viral escape could provide better strategies for vaccine development, preexposure prophylaxis, microbicides, or other therapeutic interventions.

Entities:  

Mesh:

Year:  2010        PMID: 20543609      PMCID: PMC2914479          DOI: 10.1097/COH.0b013e32833a0b9b

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  64 in total

Review 1.  Modeling sequence evolution in acute HIV-1 infection.

Authors:  Ha Youn Lee; Elena E Giorgi; Brandon F Keele; Brian Gaschen; Gayathri S Athreya; Jesus F Salazar-Gonzalez; Kimmy T Pham; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Beatrice H Hahn; George M Shaw; Bette T Korber; Tanmoy Bhattacharya; Alan S Perelson
Journal:  J Theor Biol       Date:  2009-08-04       Impact factor: 2.691

2.  Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys.

Authors:  Steven E Bosinger; Qingsheng Li; Shari N Gordon; Nichole R Klatt; Lijie Duan; Luoling Xu; Nicholas Francella; Abubaker Sidahmed; Anthony J Smith; Elizabeth M Cramer; Ming Zeng; David Masopust; John V Carlis; Longsi Ran; Thomas H Vanderford; Mirko Paiardini; R Benjamin Isett; Don A Baldwin; James G Else; Silvija I Staprans; Guido Silvestri; Ashley T Haase; David J Kelvin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

3.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

4.  CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Authors:  Nichole R Klatt; Emi Shudo; Alex M Ortiz; Jessica C Engram; Mirko Paiardini; Benton Lawson; Michael D Miller; James Else; Ivona Pandrea; Jacob D Estes; Cristian Apetrei; Joern E Schmitz; Ruy M Ribeiro; Alan S Perelson; Guido Silvestri
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

5.  In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Authors:  Joseph K Wong; Matthew C Strain; Rodin Porrata; Elizabeth Reay; Sumathi Sankaran-Walters; Caroline C Ignacio; Theresa Russell; Satish K Pillai; David J Looney; Satya Dandekar
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

6.  The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool.

Authors:  David M Butler; Mary E Pacold; Parris S Jordan; Douglas D Richman; Davey M Smith
Journal:  J Virol Methods       Date:  2009-08-19       Impact factor: 2.014

7.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

Review 8.  Specificity of the autologous neutralizing antibody response.

Authors:  Penny L Moore; Elin S Gray; Lynn Morris
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

9.  Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure.

Authors:  F K Treurnicht; C Seoighe; D P Martin; N Wood; M-R Abrahams; D de Assis Rosa; H Bredell; Z Woodman; W Hide; K Mlisana; S Abdool Karim; C M Gray; C Williamson
Journal:  Virology       Date:  2009-11-13       Impact factor: 3.616

10.  Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Rui Wang; Lauren Margolin; Jeannie Baca; Lemme Kebaabetswe; Raabya Rossenkhan; Caitlin Bonney; Michaela Herzig; David Nkwe; Sikhulile Moyo; Rosemary Musonda; Elias Woldegabriel; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more
  30 in total

Review 1.  Microbicides: topical prevention against HIV.

Authors:  Robin J Shattock; Zeda Rosenberg
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

Review 2.  Neutralizing antibodies and control of HIV: moves and countermoves.

Authors:  Ann J Hessell; Nancy L Haigwood
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

3.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

4.  Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses.

Authors:  Rajesh Abraham Jacob; Fatima Abrahams; Marcel Tongo; Michael Schomaker; Paul Roux; Eitel Mpoudi Ngole; Wendy A Burgers; Jeffrey R Dorfman
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

5.  Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Authors:  Melanie Merbah; Andrea Introini; Wendy Fitzgerald; Jean-Charles Grivel; Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

6.  Contribution of intra- and interhost dynamics to norovirus evolution.

Authors:  Rowena A Bull; John-Sebastian Eden; Fabio Luciani; Kerensa McElroy; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

7.  Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones.

Authors:  Hongru Li; Benjamin K Chen
Journal:  Virology       Date:  2018-11-08       Impact factor: 3.616

8.  Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network.

Authors:  Andrea Lisco; Arshi Munawwar; Andrea Introini; Christophe Vanpouille; Elisa Saba; Xingmin Feng; Jean-Charles Grivel; Sarman Singh; Leonid Margolis
Journal:  J Infect Dis       Date:  2011-11-22       Impact factor: 5.226

Review 9.  Recent advances in research of HIV infection: implications of viral and host genetics on treatment and prevention.

Authors:  R E Haaland; J A Johnson; J Tang
Journal:  Public Health Genomics       Date:  2013-03-18       Impact factor: 2.000

10.  Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.

Authors:  Maarten Buitendijk; Susan K Eszterhas; Alexandra L Howell
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-05       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.